EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Statin use and incident type 2 diabetes mellitus in women after menopause

Valentina Anelli, Eleni Armeni, Stavroula A Paschou, Irene Lambrinoudaki

Maturitas · 2024

DOI: 10.1016/j.maturitas.2024.107914 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Maturitas, 2024. Verfasst von Valentina Anelli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cardiovascular Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 77 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Menopause is associated with adverse cardiometabolic changes which increase the risk of new-onset type 2 diabetes (T2DM) and cardiovascular disease (CVD). Statins are widely used for primary and secondary CVD prevention, given their beneficial effects on the lipid profile and the vessel wall. On the other hand, statins increase the risk of T2DM. This association has been evaluated mainly in mixed-gender studies, without gender-specific evaluation. This narrative review evaluates the use of statins and the related risk of new-onset T2DM among postmenopausal women. Studies that incorporated a gender-specific analysis report a higher risk of new-onset T2DM in women than in men on treatment with statins. Fewer studies evaluated female-only samples; these confirm the observed association between statin use and new-onset T2DM. Factors influencing the association between statin use and T2DM include the type and dose of statin and the baseline metabolic status. Women may benefit from stratification of their metabolic risk before initiating a statin for CVD prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Hydroxymethylglutaryl-CoA Reductase InhibitorsCardiovascular DiseasesMaleFemaleHumansMenopauseSecondary PreventionRisk Factors

Stichwörter der Autor:innen

Postmenopausal womenStatinsType 2 diabetes mellitus

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
  • 2nd Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Athens, Greece; Royal Free Hospital NHS Trust, Medical School, University College London, London, UK.
  • 2nd Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Athens, Greece.
  • 2nd Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Athens, Greece. Electronic address: ilambrinoudaki@med.uoa.gr.

Zitieren

APA

Anelli, V., Armeni, E., Paschou, S. A., & Lambrinoudaki, I. (2024). Statin use and incident type 2 diabetes mellitus in women after menopause. Maturitas. https://doi.org/10.1016/j.maturitas.2024.107914

Vancouver

Anelli V, Armeni E, Paschou SA, Lambrinoudaki I. Statin use and incident type 2 diabetes mellitus in women after menopause. Maturitas. 2024. doi:10.1016/j.maturitas.2024.107914

BibTeX
@article{Anelli2024,
  author = {Anelli, Valentina and Armeni, Eleni and Paschou, Stavroula A and Lambrinoudaki, Irene},
  title = {Statin use and incident type 2 diabetes mellitus in women after menopause},
  journal = {Maturitas},
  year = {2024},
  doi = {10.1016/j.maturitas.2024.107914}
}
Kostenlos starten →